Skip to main content

Maple Leaf Green World Inc. (MGW.CN)

CNQ Healthcare Drug Manufacturers - Specialty & GenericView data quality →
39.5Poor

ValueMarkers Composite Index

Top 5%#42,705 of 44,722

DCF data not available

Piotroski
4/9
Neutral
Beneish
-
Altman
-327.57
Distress
DCF Value
-
N/A
ROIC
0.7%
Low
P/E
0.4
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Maple Leaf Green World Inc. (MGW.CN) — VMCI valuation read

MGW.CN screens at VMCI 40/100, a 11-point gap below the Healthcare sector median (50). For a mid-cap Maple Leaf Green World Inc. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

MGW.CN has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: MGW.CN trades at 26.0x earnings, 44% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 12.0% sits 2.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 0.3x leaves covenant headroom, which sets the rate-cycle exposure for Maple Leaf Green World Inc..

MGW.CN fell 3.2% over the trailing 7 days, with a -20.7% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.